American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting

MeSH terms

• Aromatase Inhibitors*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / pathology
• Breast Neoplasms / surgery
• Chemotherapy, Adjuvant
• Enzyme Inhibitors / therapeutic use*
• Female
• Humans
• Organizational Policy
• Practice Guidelines as Topic*
• Quality of Life
• Societies, Medical*
• Survival